Visalytics
Visalytics
approved EB-2 (NIW)

Student

Chemistry · Taiwan · 2025-03-25

Processing Time
303 days
Decision Date
2025-03-25
Location
Georgia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to utilize organic synthesis and structure-activity relationship (SAR) studies to develop new pharmaceutical compounds. The work focuses on creating novel chemical motifs and predictive modeling to improve therapies for antimicrobial-resistant infections and mitigate critical drug shortages.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical medical needs including antimicrobial resistance and drug shortages, which are of significant national interest.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic record of 5 publications, 81 citations, and Master's degree in pharmaceutical sciences demonstrates the capacity to succeed.

3 Balance of Interests Met

The petitioner's specialized skills in synthetic chemistry and drug development provide a benefit to the U.S. that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal articles and 81 citations, including one article ranked in the top 10% of its field. The case demonstrated national importance through alignment with pharmaceutical innovation and received scientific credibility via funding from the Ministry of Science and Technology of Taiwan. All three Dhanasar prongs were satisfied through evidence of academic impact and expert endorsements.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions

Similar Cases

Research Scientist

Research and Development · Vietnam

WeGreened EB-2 (NIW) approved
Massachusetts 820 days 2022-04-13
The petitioner proposes to continue his research on designing, synthesizing, and analyzing the structures of organic compounds, including natural products and synthetic organic compounds. This work aims to discover new therapeutic drugs and improve the processes used to design and produce pharmaceuticals.
View Case

Research Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
2 days 2023-06-07
The petitioner proposes to research and develop new chemical synthesis methods for novel therapeutic agents and implement medicinal chemical strategies for developing novel antimicrobial therapeutic agent-discovery programs. This work specifically targets pressing issues such as antimicrobial resistance, antibiotic discovery, and the treatment of Alzheimer’s disease.
View Case

Chemist

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
Pennsylvania 364 days 2025-11-26
The petitioner proposes to develop practical and efficient synthetic routes to produce active pharmaceutical ingredients (APIs) for drugs currently in clinical trials. This work focuses on improving scalable production methods to reduce costs and shorten development timelines for new therapies targeting cancer and neurodegenerative disorders.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 303 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist